GESVAL S.A. — Contact Email, Phone & Partners

Overview

GESVAL S.A. is a technology transfer and investment company established by the University of Liège and Liège University Hospital. Its mission is to manage and commercialize the intellectual property resulting from research conducted at these institutions. This involves licensing technologies to existing companies or creating spin-offs and start-ups based on university research. GESVAL S.A. manages approximately one hundred patent families and holds shares in around fifty spin-off companies on behalf of the University of Liège and Liège University Hospital. The company is also involved in managing certain major research projects for international companies. The capital of GESVAL S.A. (€8 million) is held by the University of Liège and Liège University Hospital. The board of directors is chaired by the rector of the University of Liège. GESVAL S.A. operates in the fields of technology transfer, venture capital, intellectual property management, start-ups, and spin-off companies. It focuses on early-stage investments, particularly in seed and growth stages, and is primarily active in Belgium. The company's activities include licensing technologies to existing companies and creating spin-offs and start-ups based on university research. GESVAL S.A. manages approximately one hundred patent families and holds shares in around fifty spin-off companies on behalf of the University of Liège and Liège University Hospital. The company is also involved in managing certain major research projects for international companies. The capital of GESVAL S.A. (€8 million) is held by the University of Liège and Liège University Hospital. The board of directors is chaired by the rector of the University of Liège. GESVAL S.A. operates in the fields of technology transfer, venture capital, intellectual property management, start-ups, and spin-off companies. It focuses on early-stage investments, particularly in seed and growth stages, and is primarily active in Belgium. The company's activities include licensing technologies to existing companies and creating spin-offs and start-ups based on university research. GESVAL S.A. manages approximately one hundred patent families and holds shares in around fifty spin-off companies on behalf of the University of Liège and Liège University Hospital. The company is also involved in managing certain major research projects for international companies. The capital of GESVAL S.A. (€8 million) is held by the University of Liège and Liège University Hospital. The board of directors is chaired by the rector of the University of Liège.

Investment Focus

Innovative technologies
University research outcomes
Early-stage companies
Spin-offs
Start-ups

Get the full list of 54,000+ investors

GESVAL S.A. and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription

All 54,000+ investors — VC firms, private equity, family offices and angels
The key person to contact at each one, with their job title
Their work email address
Their phone number
Their LinkedIn profile
Delivered as a single .xlsx file — download it as many times as you like

Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about GESVAL S.A.

What sectors does GESVAL S.A. invest in?

GESVAL S.A. invests in Venture Capital, Start-ups, Technology Transfer, Intellectual Property Management and Spin-off Companies, and is based in Wallonia, Belgium. GESVAL S.A. is listed as a other in the ConnectSafely investor database.